Senti Bio adjourns annual meeting to Oct 15 to solicit votes for merger proposal

Senti Biosciences, Inc.

2026 Annual Meeting convened virtually on Oct 8, 2026 and was adjourned without conducting any business even though a quorum was present.
Adjournment is to gain more time to solicit votes in favor of the Merger Agreement Proposal described in the Sept 24, 2026 definitive proxy statement.
Meeting reconvenes Thursday, Oct 15, 2026 at 8:00 a.m. Pacific at virtualshareholdermeeting.com/SNTI2026; no proposals changed and all polls stay open.
Record date remains Sept 23, 2026; stockholders who already voted need take no action unless they want to change their vote.
Filing gives no merger counterparty, deal terms or vote tally; SNTI common stock trades on the Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.